Similar Search Results

The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France

Lichtenberg, Frank R. - 2014

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I examine the effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality rates of residents of Germany, using...

Persistent link: https://www.econbiz.de/10013069689

Medical innovations and ageing : a health economics perspective

Grossmann, Volker - 2021

surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health …This paper discusses the relationship between medical innovations and ageing from a health economics perspective and … conceptualization of ageing as an accumulation of health deficits. The paper also discusses the role of medical progress for longevity …

Persistent link: https://www.econbiz.de/10012653346

Private versus social incentives for pharmaceutical innovation

González, Paula; Macho-Stadler, Inés; … - 2015

We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...

Persistent link: https://www.econbiz.de/10011406575

Adoption of new technology vaccines

Zimmermann, Laura; Somasundaram, Jeeva; Saha, Barsha - In: Journal of marketing 88 (2024) 4, pp. 1-21

Persistent link: https://www.econbiz.de/10014582924

Pharmaceutical innovation and health outcomes : empirical evidence from Taiwan

Hsieh, Chee-Ruey; Lo, Kuang-ta Vance; Hong, Yichen; … - In: Pharmaceutical innovation : incentives, competition, …, (pp. 242-261). 2007

Persistent link: https://www.econbiz.de/10003499023

[Rezension von: Pharmaceutical innovation: revolutionizing human health, ed. by Ralph Landau ...]

Comanor, William S. - In: Journal of economic literature 39 (2001) 3, pp. 944-945

Persistent link: https://www.econbiz.de/10001612430

Patient welfare and patient compliance : an empirical framework for measuring the benefits from pharmaceutical innovation

Ellickson, Paul; Stern, Scott; Trajtenberg, Manuel - 1999

Persistent link: https://www.econbiz.de/10001355791

Does medicaid pay too much for precscription drugs? : A case study of atypical anti-psychotics

Duggan, Mark G. - 2003

Persistent link: https://www.econbiz.de/10001753201

The TRIPS waiver proposal: an urgent measure to expand access to the COVID-19 vaccines

Menezes, Henrique Zeferino de - 2021

Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of vaccination is marked by the deepening of vaccine...

Persistent link: https://www.econbiz.de/10012496070

Medizinische Innovationen für Afrika : Forschung und Produktentwicklung zur Bekämpfung vernachlässigter Krankheiten

Gerlinger, Katrin - 2017 - 1. Auflage

A lack of drugs with which to combat poverty-related diseases is a global health problem. This book presents various …

Persistent link: https://www.econbiz.de/10012015246

1
2
3
4
5
6
7
8
9
10
Next
Last